Abstract:Alzheimer's disease (AD) is a severe irreversible neurodegenerative disease that has great sufferings on patients and eventually leads to death. Early detection of AD and its prodromal stage, mild cognitive impairment (MCI) which can be either stable (sMCI) or progressive (pMCI), is highly desirable for effective treatment planning and tailoring therapy. Recent studies recommended using multimodal data fusion of genetic (single nucleotide polymorphisms, SNPs) and neuroimaging data (magnetic resonance imaging (MRI) and positron emission tomography (PET)) to discriminate AD/MCI from normal control (NC) subjects. However, missing multimodal data in the cohort under study is inevitable. In addition, data heterogeneity between phenotypes and genotypes biomarkers makes learning capability of the models more challenging. Also, the current studies mainly focus on identifying brain disease classification and ignoring the regression task. Furthermore, they utilize multistage for predicting the brain disease progression. To address these issues, we propose a novel multimodal neuroimaging and genetic data fusion for joint classification and clinical score regression tasks using the maximum number of available samples in one unified framework using convolutional neural network (CNN). Specifically, we initially perform a technique based on linear interpolation to fill the missing features for each incomplete sample. Then, we learn the neuroimaging features from MRI, PET, and SNPs using CNN to alleviate the heterogeneity among genotype and phenotype data. Meanwhile, the high learned features from each modality are combined for jointly identifying brain diseases and predicting clinical scores. To validate the performance of the proposed method, we test our method on 805 subjects from Alzheimer's Disease Neuroimaging Initiative (ADNI) dataset. Also, we verify the similarity between the synthetic and real data using statistical analysis. Moreover, the experimental results demonstrate that the proposed method can yield better performance in both classification and regression tasks. Specifically, our proposed method achieves accuracy of 98.22%, 93.11%, and 97.35% for NC vs. AD, NC vs. sMCI, and NC vs. pMCI, respectively. On the other hand, our method attains the lowest root mean square error and the highest correlation coefficient for different clinical scores regression tasks compared with the state-of-the-art methods.

Patch-based Interpretable Deep Learning Framework for Alzheimer’s Disease Diagnosis Using Multimodal Data

Patch-based Deep Multi-Modal Learning Framework for Alzheimer’s Disease Diagnosis Using Multi-View Neuroimaging

Early Diagnosis of Alzheimer's Disease Using Deep Learning

Alzheimer’s Disease Diagnosis Via Multimodal Feature Fusion

Deep Multi-Modal Discriminative and Interpretability Network for Alzheimer's Disease Diagnosis

Multi-scale multimodal deep learning framework for Alzheimer's disease diagnosis

Development and validation of an interpretable deep learning framework for Alzheimer's disease classification

Alzheimer's disease diagnosis framework from incomplete multimodal data using convolutional neural networks

A Multimodal Learning Machine Framework for Alzheimer’s Disease Diagnosis Based on Neuropsychological and Neuroimaging Data

Multimodal Cross Enhanced Fusion Network for Diagnosis of Alzheimer's Disease and Subjective Memory Complaints.

Development and validation of a deep learning framework for Alzheimer’s disease classification

Deep learning and multimodal feature fusion for the aided diagnosis of Alzheimer's disease

Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer’s Disease using structural MR and FDG-PET images

Deep joint learning diagnosis of Alzheimer's disease based on multimodal feature fusion

Multimodal cross enhanced fusion network for diagnosis of Alzheimer?s disease and

A Feature-Aware Multimodal Framework with Auto-Fusion for Alzheimer’s Disease Diagnosis

A feature-aware multimodal framework with auto-fusion for Alzheimer's disease diagnosis

Multimodal deep learning models for early detection of Alzheimer’s disease stage

Joint Learning Framework of Cross-Modal Synthesis and Diagnosis for Alzheimer's Disease by Mining Underlying Shared Modality Information.

Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer's Disease using structural MR and FDG-PET images

Multimodal deep learning for Alzheimer’s disease dementia assessment